NCT06808282 is a NA clinical trial of White chocolate in Cardiovascular Diseases, sponsored by San Diego State University.

Who is sponsoring NCT06808282?

NCT06808282 is sponsored by San Diego State University.

What drugs are being tested in NCT06808282?

Interventions in NCT06808282: White chocolate, Dark chocolate.

What condition does NCT06808282 study?

NCT06808282 studies Cardiovascular Diseases.

Is NCT06808282 still recruiting?

NCT06808282 is currently active, enrolled. Last updated 5 February 2026.

Last reviewed 2026-02-05 · How we verify

NCT06808282

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Dark Chocolate on the Risk Factors of Cardiovascular Diseases

Active, enrolled NA Last updated 5 February 2026

What this trial tests

NA trial testing White chocolate in Cardiovascular Diseases in 45 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

1 April 2011

Primary endpoint
31 December 2026

31 December 2026

Quick facts

Lead sponsor	San Diego State University
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	45
Start date	1 April 2011
Primary completion	31 December 2026
Estimated completion	31 December 2026
Sites	1 location across United States

Drugs / interventions tested

White chocolate
Dark chocolate — full drug profile →

Conditions studied

Cardiovascular Diseases — all drugs for Cardiovascular Diseases →

Sponsor

San Diego State University

Who can join

Adults 21 to 60, any sex, with Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cardiovascular disease (CVD) is the number one cause of death in the US. Epidemiologic evidence supports that antioxidant-rich diets promote health and attenuate or delay the onset of CVD. Cocoa and chocolate products have among the highest antioxidant concentrations compared to other antioxidant food sources. The objective of this study is to examine the effects of regular dark chocolate, bloomed dark chocolate, and white chocolate on cardiovascular health markers.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Comparative effects of regular, bloomed or white chocolate on cardiovascular and antioxidant markers in healthy adults.
Chatagnier L, Orsa C, Plumlee D, Wright A, et al · · 2026 · PMID 42004823 · DOI 10.1016/j.metop.2026.100465

Verify or expand the search:

Other trials of White chocolate

Trials testing the same drug.

NCT06073327 — Short-term Cocoa Supplementation and Elite Soccer Players · NA · completed
NCT05755217 — Renal Ultrasound Response After Chocolate Consumption · NA · recruiting
NCT03637829 — Effect of Morning Snack on Cognitive Performance in Adults · NA · completed

Other recruiting trials for Cardiovascular Diseases

Currently open trials in the same condition.

NCT07442578 — Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial · NA · active not recruiting
NCT07426263 — Effectiveness of a Therapeutic Education Program on Female Sexuality in Women Attending Cardiac Rehabilitation. · NA · active not recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07324278 — Hybrid Stroke Rehab With Mirror Priming · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting

Other San Diego State University trials

Trials by the same sponsor.

NCT06900634 — Pilot of an Intervention to Reduce Alcohol Use and Improve ART Adherence Among Men Living With HIV With Pregnant Partner · NA · not yet recruiting
NCT07271290 — Preventing Noise Exposure in Farmworkers · NA · not yet recruiting
NCT07010133 — Be Well at Work-Plus: A Depression and Physical Activity Intervention for Hospital Service Workers (Aim 3) · NA · not yet recruiting
NCT06753123 — Be Well at Work-Plus: A Depression and Physical Activity Intervention for Hospital Service Workers (Aim 2) · NA · not yet recruiting
NCT06635642 — Auditory Research in Children Living With HIV Exposure-uninfected (ARCHIVE) · NA · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06808282 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by San Diego State University
Last refreshed: 5 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06808282.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing